{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-118073","form_type":"8-K","ticker":null,"cik":"0001808158","company_name":"Repare Therapeutics Inc.","filed_at":"2024-04-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.234617+00:00","generated_at":"2026-06-03T06:38:34.830631+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Repare Therapeutics appoints Steven H. Stein to board; Todd Foley not seeking re-election","bullets":["Todd Foley will not stand for re-election as Class I director at June 17, 2024 annual meeting after 7+ years.","Steven H. Stein, M.D., appointed as Class II director effective June 2024 annual meeting.","Dr. Stein is Chief Medical Officer of Incyte Corporation; joins Science & Technology Committee.","Stein will receive option to purchase 54,400 common shares under standard non-employee director compensation."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-118073","json":"https://secwatch.observer/filing/0001193125-24-118073.json","markdown":"https://secwatch.observer/filing/0001193125-24-118073.md","text":"https://secwatch.observer/filing/0001193125-24-118073.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1808158/000119312524118073/0001193125-24-118073-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1808158/000119312524118073/d798198d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T06:38:34.830631+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"542df14e9d","claim":"Steven H. Stein was appointed as Class II Director at Repare Therapeutics Inc..","evidence_excerpt":"On April 25, 2024, upon the recommendation of the Nominating and Corporate Governance Committee, the Board appointed Steven H. Stein, M.D. to serve as a Class II director of the Company, effective as of the Annual Meeting Date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1808158/000119312524118073/0001193125-24-118073-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class II Director"}],"fact_type":"executive_change"},{"claim_id":"89274d9277","claim":"Todd Foley departed as Class I Director at Repare Therapeutics Inc..","evidence_excerpt":"On April 24, 2024, Todd Foley notified the board of directors (the “ Board ”) of Repare Therapeutics, Inc. (the “ Company ”) of his decision not to stand for re-election as a Class I director following the end of his current term on June 17, 2024","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1808158/000119312524118073/0001193125-24-118073-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"not stand for re-election"},{"label":"Role","value":"Class I Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}